SCHEMBL4435960

SCHEMBL4435960

CCCC[C@H](C)CC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.52
ACE2 Q9BYF1 1/20 0.50
CA2 P00918 1/20 0.46
MAPK1 P28482 1/20 0.46
MAPT P10636 1/20 0.44
BHMT Q93088 1/20 0.44
AKR1B1 P15121 1/20 0.42
PPARG P37231 4/20 0.41
PPARD Q03181 4/20 0.41
PPARA Q07869 4/20 0.41
TSHR P16473 3/20 0.41
HDAC11 Q96DB2 3/20 0.41
ALDH1A1 P00352 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
SLC22A8 Q8TCC7 1/20 0.41
TLR2 O60603 1/20 0.41
MEN1 O00255 1/20 0.41
ESR1 P03372 1/20 0.41
FABP4 P15090 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL301256 1.00 GPR84 (0.52) GPR84ACE2CA2MAPK1MAPT
SCHEMBL905453 1.00 GPR84 (0.52) GPR84ACE2CA2MAPK1MAPT
Hydrochloric Acid SCHEMBL27778084 0.98 GPR84 (0.50) GPR84ACE2CA2MAPK1MAPT
SCHEMBL28055317 0.98 GPR84 (0.50) GPR84ACE2CA2MAPK1MAPT
SCHEMBL5858405 0.94 ACE2 (0.60) GPR84ACE2CA2MAPK1MAPT
SCHEMBL544052 0.93 GPR84 (0.61) GPR84ACE2MAPTAKR1B1PPARG
SCHEMBL30882121 0.93 GPR84 (0.61) GPR84ACE2MAPTAKR1B1PPARG
SCHEMBL23930717 0.91 GPR84 (0.64) GPR84ACE2MAPTPPARGPPARD
SCHEMBL17772493 0.91 GPR84 (0.64) GPR84ACE2MAPTPPARGPPARD
SCHEMBL22612526 0.91 GPR84 (0.64) GPR84ACE2MAPTPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118894772-A Preparation method of key intermediate of high optical purity limaprost 常州博海威医药科技股份有限公司 2024-11-05 CN claimed
EP-0638059-A1 PROCESS FOR THE PREPARATION OF 3(S)-METHYLHEPTANOIC ACID AND INTERMEDIATES THEREFOR PFIZER INC. (US) 1995-02-15 EP claimed
US-5286904-A Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine PFIZER INC. (US) 1994-02-15 US claimed
WO-1993022269-A1 PROCESS FOR THE PREPARATION OF 3(S)-METHYLHEPTANOIC ACID AND INTERMEDIATES THEREFOR PFIZER INC. (US) 1993-11-11 WO claimed
US-5248820-A Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor PFIZER INC. (US) 1993-09-28 US claimed
WO-1988001613-A1 CRYSTALLINE N-(S-3-METHYLHEPTANOYL)-D-GAMMA-GLUTAMYL-GLYCYL-D-ALANINE, AND PROCESSES AND INTERMEDIATES THEREFOR PFIZER INC. (US) 1988-03-10 WO claimed
WO-1988001612-A1 PROCESSES AND INTERMEDIATES FOR N-(S-3-ALKYL-HEPTANOYL)-D-GAMMA-GLUTAMYL-GLYCYL-D-ALANINE PFIZER INC. (US) 1988-03-10 WO claimed
EP-0259084-A2 Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor PFIZER INC. (US) 1988-03-09 EP claimed
EP-0258032-A2 Processes and intermediates for N-(S-3-alkylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine PFIZER INC. (US) 1988-03-02 EP claimed
EP-0227078-A1 Process for preparing (S)-alpha-methylarylacetic acids WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1987-07-01 EP claimed
CN-121472200-A Nitrilase mutant and application thereof in preparation of (S) -3-methylheptanoic acid 杭州微远生物科技有限公司 2026-02-06 CN disclosed
CN-121472200-A Nitrilase mutant and application thereof in preparation of (S) -3-methylheptanoic acid 杭州微远生物科技有限公司 2026-02-06 CN disclosed
CN-118894772-A Preparation method of key intermediate of high optical purity limaprost 常州博海威医药科技股份有限公司 2024-11-05 CN disclosed
CN-118894772-A Preparation method of key intermediate of high optical purity limaprost 常州博海威医药科技股份有限公司 2024-11-05 CN disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
EP-0227306-A2 Peptide immunostimulants PFIZER INC. (US) 1987-07-01 EP disclosed
EP-0227078-A1 Process for preparing (S)-alpha-methylarylacetic acids WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1987-07-01 EP disclosed
US-4564620-A 5,6,7,-Trinor-4,8-inter-m-phenylene PGI2 derivatives and anti-ulcer, anti-thrombotic and anti-hypertensive pharmaceutical compositions containing them TORAY INDUSTRIES, INC. (JP) 1986-01-14 US disclosed
EP-0060640-B1 5,6,7-TRINOR-4,8-INTER-M-PHENYLENE PGI DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM TORAY INDUSTRIES, INC. (JP) 1985-11-13 EP disclosed
EP-0060640-A1 5,6,7-Trinor-4,8-inter-m-phenylene PGI derivatives and pharmaceutical compositions containing them TORAY INDUSTRIES, INC. (JP) 1982-09-22 EP disclosed